The CurePPaC Study - Analysing Non-surgical Treatment Strategies to Cure Pes Planovalgus Associated Complaints

October 25, 2017 updated by: Heiner Baur (PhD), Bern University of Applied Sciences
Pes planovalgus, also called flat foot, is a common foot deformity characterized by a flattening of the foot's longitudinal arch and is accompanied by a dysfunction of the posterior tibial tendon ("posterior tibial tendon dysfunction" or "PTTD"). Early stages of this pathology are thought to be treated with non-surgical therapy options like foot orthoses (relief of tendon stress by mechanical unloading of the arch), strengthening exercises or basic physiotherapeutic measures. Recent literature clearly states the urgent need for high quality studies to evaluate the proposed non-surgical treatments (Bowring 2009, 2010). There is only one high quality study available that shows benefits of orthoses therapy and exercise (Kulig 2009). No study to date evaluated functional changes pre-post in dynamic movement pattern like gait or stair climbing. The widespread use of several non-surgical treatment strategies lead to extensive financial expenses of the health care system. An optimized therapeutic strategy could eventually lead to more efficient health care investments. The presented proposal addresses this latest knowledge and aims to analyse non-surgical treatment strategies to Cure Pes Planovalgus associated Complaints (CurePPaC) in the CurePPaC Study.

Study Overview

Detailed Description

Introduction: Pes planovalgus or flatfoot-associated complaints are frequent symptoms, which are thought to be caused by the foot deformity itself. Concurrently, the multifactorial weakness of the M. tibialis posterior and its tendon (trauma, systemic disease, chronic tendon degeneration by overuse) can lead to a flattening of the medial longitudinal arch of the foot. Affected patients suffer from functional impairment and pain. Less severe cases are eligible for non-surgical treatment. Foot orthoses are considered to be the first line approach. Furthermore strengthening of the arch and ankle stabilizing muscles are thought to contribute to an active compensation of the deformity. There is only limited evidence concerning the numerous therapy approaches since high quality studies are missing. One excellent report (Kulig et al. 2009) shows clear benefits by the use of foot orthoses and eccentric strengthening exercises. Beside the fact that evidence-based guidelines for therapy have yet to be developed, no data is available showing functional benefits that accompany the therapy process. This would give further insight into mechanisms behind non-surgical management strategies and how patients benefit functionally from therapy. Purpose: The purpose of this randomized longitudinal intervention study is the evaluation of the therapeutic benefit of three different non-surgical treatment regimens (foot orthoses only FOO, foot orthoses and eccentric exercise FOE, foot orthoses sham treatment FOS) in patients with Pes planovalgus and accompanying complaints. Furthermore the analysis of possible functional changes in gait mechanics (kinematic and kinetic view) and neuromuscular control (electromyographic analysis) will contribute to a superior understanding of functional changes that accompany non-operative management. The purpose of the study is to optimize non-surgical management in patients suffering from Pes planovalgus associated pain leading to an efficient use of health care system's financial resources. Methods: 60 patients with Pes planovalgus associated complaints (clinical diagnosis with plain weight bearing radiographs), M. tibialis posterior dysfunction) are included in the study. Functional impairment is evaluated pre and post intervention by the Foot-Function-Index (FFI, German version). Anthropometric data recording is followed by preparation of subject's foot anatomical landmarks with retroreflective markers and superficially detectable muscles of the ankle joint complex are prepared with surface electromyography (SEMG) electrodes. The 3D kinematic data allows inter alia the calculation of segmental angels of the lower extremity and measurement of navicular drop. The neuromuscular activity is analysed in the time (on-off pattern) and amplitude domain (gait cycle specific phases). Procedure: Potential participants are recruited via the Outpatient Clinic of the Department of Orthopaedic Surgery of the Inselspital, University Hospital, Bern. After initial screening, subjects are randomized to one of three intervention groups (foot orthoses only FOO, foot orthoses and eccentric exercise FOE, foot orthoses sham treatment FOS). FOO-subjects wear custom-made foot orthoses only. FOE-subjects wear individually accustomed foot orthoses and they will perform a combined monitored and home training program to progressively strengthen the M. tibialis posterior and accompanying ankle stabilizing muscles with eccentric exercises. FOS-subjects wear custom-made sham foot orthoses without the functional elements of the treatment orthoses (longitudinal arch support, ankle stabilizer, bowl-shaped heel for rearfoot stability). Subjects are measured pre and post intervention (12 weeks). Measurements include the primary outcome measure Foot-Function-Index (FFI, German version: total score) followed by basic anthropometric measures. Subject preparation allows then the measurement of 10 trials on a walkway and on stairs with embedded force plates in barefoot condition. An average step cycle out of 10 trials is calculated and biomechanical outcome measures are extracted. A re-test allows the calculation of intervention effects by one-factor ANOVA (group: treatment FOO vs. FOE vs. FOS) for repeated measures.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3001
        • Spital Netz Bern Ziegler
      • Bern, Switzerland, 3006
        • Klinik Sonnenhof Bern
      • Bern, Switzerland, 3012
        • Inselspital, University Hospital Bern
      • Bern, Switzerland, 3013
        • Salem Spital Bern
      • Bern, Switzerland, 3013
        • Salem-Spital Orthopädische Klinik Bern
      • Thun, Switzerland, 3600
        • Spital STS AG

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 18-60
  • Current complaint of foot and ankle pain that lasted for 3 months or more
  • Flexible Pes planovalgus deformity in the clinical assessment
  • Posterior tibial tendon dysfunction (PTTD) of stage I and II (Johnson & Strom 1989)
  • Pes planovalgus foot deformity with longitudinal arch flattening verified by radiograph (Younger 2005): Lateral view: lateral talo-first metatarsal angle ≠ 0° (break of axis): angle >10° according to Younger (2005); 60Anteroposterior view: anteroposterior talo-first metatarsal angle ≠ 0° (break of axis): angle >10° according to Younger (2005)
  • "too-many toes"-sign from rear frontal view with an abducted forefoot (Johnson & Strom 1989, Kulig 2009b)
  • Eligibility for non-surgical treatment
  • No indication / not yet an indication for surgical treatment of foot deformity

Exclusion Criteria:

  • Rigid foot deformity
  • Posterior tibial tendon dysfunction (PTTD) of stage III and IV according to Johnson & Strom 1989 (=>rigid foot deformity)
  • Cardio-, neuro-, or peripheral vascular pathology, musculoskeletal pathology, acute infection or alcohol addiction limiting participation in study protocol
  • Acute use of local or systemic analgesics
  • Acute physical therapy, training therapy or physiotherapy
  • Acute overuse or traumatic injury to the lower leg (excluding Pes planovalgus associated pathology)
  • Prior surgery to the lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Foot Orthoses Only
including Patient Education; Abbreviation: FOO
patients wear foot orthoses as a treatment condition - no further therapy
Experimental: Foot Orthoses and Eccentric Exercise
including Patient Education; Abbreviation: FOE
patients wear foot orthoses and they perform an additional home-based eccentric training program for the M. tibialis posterior
Sham Comparator: Sham Foot Orthoses
including Patient Education; Abbreviation: FOS
patient wear sham foot orthoses (control condition)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot Function Index - total score
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
additional analysis of change from baseline to week 4, and analysis of change from baseline to week 8
change from baseline (pre intervention) to week 12 (post intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot Function Index - subcategory pain
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
additional analysis of change from baseline to week 4, and analysis of change from baseline to week 8
change from baseline (pre intervention) to week 12 (post intervention)
Foot Function Index - subcategory disability
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
additional analysis of change from baseline to week 4, and analysis of change from baseline to week 8
change from baseline (pre intervention) to week 12 (post intervention)
Foot Function Index - subcategory activity limitation
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
additional analysis of change from baseline to week 4, and analysis of change from baseline to week 8
change from baseline (pre intervention) to week 12 (post intervention)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Disability Index
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
additional analysis of change from baseline to week 4, and analysis of change from baseline to week 8
change from baseline (pre intervention) to week 12 (post intervention)
Visual Analogue Scale
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
assessing pain pre- and post biomechanical testing / change from baseline to week 12
change from baseline (pre intervention) to week 12 (post intervention)
kinematic data from 3d movement analysis
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
regarding distance: navicular drop; regarding angular data (angle at initial contact, max. manifestation during stance, range): foot progression angle, forefoot to rearfoot dorsiflexion, forefoot to rearfoot adduction, forefoot to rearfoot supination, ankle dorsiflexion, ankle adduction, ankle eversion, knee flexion, knee adduction, knee internal rotation, hip flexion, hip adduction, hip internal rotation
change from baseline (pre intervention) to week 12 (post intervention)
neuromuscular activity
Time Frame: change from baseline (pre intervention) to week 12 (post intervention)
EMG of M. tibialis anterior, M. peroneus longus, M. gastrocnemius lateralis/medialis, M. soleus: onset of activation, time of maximum activation, total time of activation, normalized amplitude in preactivation, normalized amplitude in weight acceptance, normalized amplitude in mid-stance, normalized amplitude in push-off
change from baseline (pre intervention) to week 12 (post intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heiner Baur, PhD, Bern University of Applied Sciences, Switzerland
  • Principal Investigator: Heiner Baur, PhD, Bern University of Applied Sciences, Health, aR&D Physiotherapy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

October 25, 2017

Study Completion (Actual)

October 25, 2017

Study Registration Dates

First Submitted

April 17, 2013

First Submitted That Met QC Criteria

April 22, 2013

First Posted (Estimate)

April 25, 2013

Study Record Updates

Last Update Posted (Actual)

October 27, 2017

Last Update Submitted That Met QC Criteria

October 25, 2017

Last Verified

October 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foot Injuries

Clinical Trials on Foot Orthoses Only

Subscribe